| Literature DB >> 34939828 |
Cheng Chen1,2, Kathleen M Hayden3, Joel D Kaufman4, Mark A Espeland5, Eric A Whitsel6, Marc L Serre7, William Vizuete7, Tonya S Orchard8, Xinhui Wang9, Helena C Chui9, Mary E D'Alton1, Jiu-Chiuan Chen9,10, Ka Kahe1,2.
Abstract
BACKGROUND: Previous studies suggest that certain dietary patterns and constituents may be beneficial to brain health. Airborne exposures to fine particulate matter [particulate matter with aerodynamic diameter ≤2.5μm (PM2.5)] are neurotoxic, but the combined effects of dietary patterns and PM2.5 have not been investigated.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34939828 PMCID: PMC8698852 DOI: 10.1289/EHP8036
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
MIND Diet component serving and scoring.
| Categories | Score | ||
|---|---|---|---|
| 0 | 0.5 | 1 | |
| Brain-healthy foods | — | — | — |
| Leafy greens |
| 2–6 servings/wk |
|
| Other vegetables |
| 5–7 servings/wk |
|
| Beans |
| 1–3 servings/wk |
|
| Whole grains |
| 1–2.6 servings/d |
|
| Berries |
| 1–2 servings/wk |
|
| Nuts | Rarely |
|
|
| Nonfried fish | Rarely |
|
|
| Nonfried poultry |
| 1–2 servings/wk |
|
| Olive and canola oils | Not primary oil used | — | Primary oil used |
| Wine |
| 1 glass/d | |
| Brain-unhealthy foods | — | — | — |
| Butter or margarine |
| 0.5–1 serving/d |
|
| Cheese |
| 1–7 servings/wk |
|
| Red meat |
| 4–7 servings/wk |
|
| Fried foods |
| 1–4 servings/wk |
|
| Pastries and sweets |
| 5–7 servings/wk |
|
| Total score | — | — | 15 |
Note: The MIND score was retrospectively calculated based on the intakes of 15 dietary components including 10 brain healthy food groups and 5 unhealthy food groups using WHI food frequency questionnaire at baseline (1996–1998). Olive and canola oil consumption was assigned a score of 1 if it was identified as the primary oil used at home, and a score of 0 otherwise. Wine consumption was scored such that women who drank 1 glass/d were assigned a score of 1, and women who occasionally drank wine ( ) were assigned a score of 0.5, whereas women were assigned a score of 0 if they never drank wine or if they drank . For all other dietary components, corresponding component scores were assigned based on the consumption frequency of foods in each group, with scores of 0, 0.5, and 1 assigned for low, medium, and high (respectively) consumption of “brain healthy” foods, and scores of 0, 0.5, and 1 assigned for high, medium, and low (respectively) consumption of brain-unhealthy foods. The total MIND score was computed by summing over the 15 component scores, with a higher value indicating a higher likelihood to consume a MIND dietary pattern. The MIND diet was originally constructed in the Rush Memory and Aging Project (MAP) (Morris et al. 2015a). —, no data; MIND, Mediterranean–DASH Intervention for Neurodegenerative Delay; WHI, Women’s Health Initiative.
Baseline (1996–1998) characteristics of the study population by quartiles (Q) of baseline MIND score ().
| Categories | Total | Quartiles of MIND scores (points) | ||||
|---|---|---|---|---|---|---|
| Q1 ( | Q2 (5.6–6.5) | Q3 (6.6–7.5) | Q4 ( | |||
|
| 1,302 | 364 | 298 | 298 | 342 | — |
| Median points | 6.5 | 5.0 | 6.3 | 7.0 | 8.5 | — |
| Age (y) |
|
|
|
|
| 0.0074 |
| Race/ethnicity | — | — | — | — | — | 0.0051 |
| Non-Hispanic White | 1,193 (91.6) | 345 (28.9) | 274 (23.0) | 275 (23.0) | 299 (25.1) | — |
| Other | 109 (8.4) | 19 (17.4) | 24 (22.0) | 23 (21.1) | 43 (39.5) | — |
| U.S. region | — | — | — | — | — |
|
| Northeast | 304 (23.3) | 72 (23.7) | 58 (19.1) | 80 (26.3) | 94 (30.9) | — |
| South | 186 (14.3) | 46 (24.7) | 41 (22.1) | 53 (28.5) | 46 (24.7) | — |
| Midwest | 465 (35.7) | 171 (36.8) | 130 (27.9) | 83 (17.9) | 81 (17.4) | — |
| West | 347 (26.7) | 75 (21.6) | 69 (19.9) | 82 (23.6) | 121 (34.9) | — |
| Education | — | — | — | — | — |
|
| Less than high school | 54 (4.1) | 25 (46.3) | 8 (14.8) | 10 (18.5) | 11 (20.4) | — |
| High school graduate or equivalents | 298 (22.9) | 118 (39.6) | 75 (25.2) | 51 (17.1) | 54 (18.1) | — |
| College graduate or higher degree | 950 (73.0) | 221 (23.2) | 215 (22.6) | 237 (25.0) | 277 (29.2) | — |
| Employment | — | — | — | — | — | 0.21 |
| Currently employed | 236 (18.1) | 77 (32.6) | 49 (20.8) | 51 (21.6) | 59 (25.0) | — |
| Currently not employed | 139 (10.7) | 40 (28.8) | 27 (19.4) | 26 (18.7) | 46 (33.1) | — |
| Retired | 927 (71.2) | 247 (26.6) | 222 (24.0) | 221 (23.8) | 237 (25.6) | — |
| Smoking status | — | — | — | — | — | 0.034 |
| Never | 751 (57.7) | 232 (30.9) | 174 (23.2) | 167 (22.2) | 178 (23.7) | — |
| Former | 494 (37.9) | 114 (23.1) | 110 (22.2) | 118 (23.9) | 152 (30.8) | — |
| Current | 57 (4.4) | 18 (31.6) | 14 (24.6) | 13 (22.8) | 12 (21.0) | — |
| Alcohol consumption | — | — | — | — | — |
|
| Never | 163 (12.5) | 60 (36.8) | 39 (23.9) | 29 (17.8) | 35 (21.5) | — |
| Former | 213 (16.4) | 75 (35.2) | 49 (23.0) | 44 (20.7) | 45 (21.1) | — |
| Current | 777 (59.7) | 205 (26.4) | 179 (23.0) | 194 (25.0) | 199 (25.6) | — |
| Current | 149 (11.4) | 24 (16.1) | 31 (20.8) | 31 (20.8) | 63 (42.3) | — |
| BMI | — | — | — | — | — |
|
| | 391 (30.0) | 80 (20.5) | 82 (21.0) | 92 (23.5) | 137 (35.0) | — |
| | 491 (37.7) | 129 (26.2) | 124 (25.3) | 114 (23.2) | 124 (25.3) | — |
| | 420 (32.3) | 155 (36.9) | 92 (21.9) | 92 (21.9) | 81 (19.3) | — |
| Moderate or strenuous activities | — | — | — | — | — |
|
| No activity | 733 (56.3) | 253 (34.5) | 183 (25.0) | 147 (20.0) | 150 (20.5) | — |
| Some activity | 76 (5.8) | 19 (25.0) | 17 (22.4) | 16 (21.0) | 24 (31.6) | — |
| 2–4 episodes/wk | 261 (20.1) | 64 (24.5) | 51 (19.5) | 66 (25.3) | 80 (30.7) | — |
| | 232 (17.8) | 28 (12.1) | 47 (20.3) | 69 (29.7) | 88 (37.9) | — |
| Total energy intake (kcal/d) | 1,536 (1,160–1,939) | 1,669 (1,257–2,081) | 1,565 (1,159–1,919) | 1,454 (1,092–1,868) | 1,454 (1,117–1,803) |
|
| Baseline 3MS score (points) | 97 (95–99) | 97 (95–98) | 97 (95–99) | 97 (95-99) | 97 (94–99) | 0.18 |
| Hypertension (self-report, medications, or measured elevated BP) | — | — | — | — | — |
|
| No | 634 (48.7) | 177 (27.9) | 144 (22.7) | 145 (22.9) | 168 (26.5) | — |
| Yes | 668 (51.3) | 187 (28.0) | 154 (23.1) | 153 (22.9) | 174 (26.0) | — |
| Diabetes (self-report or medications) | — | — | — | — | — | 0.80 |
| No | 1,257 (96.5) | 352 (28.0) | 285 (22.7) | 289 (23.0) | 331 (26.3) | — |
| Yes | 45 (3.5) | 12 (26.7) | 13 (28.9) | 9 (20.0) | 11 (24.4) | — |
| Hypercholesterolemia (self-report or medications) | — | — | — | — | — | 0.0057 |
| No | 1,094 (84.0) | 321 (29.3) | 258 (23.6) | 237 (21.7) | 278 (25.4) | — |
| Yes | 208 (16.0) | 43 (20.7) | 40 (19.2) | 61 (29.3) | 64 (30.8) | — |
| Cardiovascular disease (self-report) | — | — | — | — | — | 0.34 |
| No | 1,121 (86.1) | 316 (28.2) | 249 (22.2) | 254 (22.7) | 302 (26.9) | — |
| Yes | 181 (13.9) | 48 (26.5) | 49 (27.1) | 44 (24.3) | 40 (22.1) | — |
| WHI-HRT treatment assignment | — | — | — | — | — | 0.62 |
| Estrogen-alone intervention | 242 (18.6) | 75 (31.0) | 58 (24.0) | 55 (22.7) | 54 (22.3) | — |
| | 405 (31.1) | 112 (27.7) | 84 (20.7) | 98 (24.2) | 111 (27.4) | — |
| Placebo | 655 (50.3) | 177 (27.1) | 156 (23.8) | 145 (22.1) | 177 (27.0) | — |
| 3-y moving average |
|
|
|
|
| 0.050 |
Note: Results are presented as deviations and medians (interquartile ranges) for continuous variables and counts (percent across quartiles of MIND score) for categorical variables. p-Values are for any difference across quartiles of MIND score (Kruskal-Wallis test or chi-square test, as appropriate). —, no data; BMI, body mass index; BP, blood pressure; min, minutes; MIND, Mediterranean–DASH Intervention for Neurodegenerative Delay; WHI-HRT, Women’s Health Initiative Hormone Replacement Therapy trial; 3MS, the modified Mini-Mental State.
Disaggregated data for participants in the “Other” race/ethnicity group is provided in Table S5.
Multivariable linear regression of normal-appearing brain volumes (measured by MRI in 2005–2006) with baseline MIND score ().
| Categories | Adjusted | Unadjusted | Benjamini-Hochberg |
|---|---|---|---|
| Total brain | 0.10 ( | 0.47 | 0.90 |
| Normal brain | 0.23 ( | 0.23 | 0.90 |
| Total white matter | 0.74 (0.001, 1.48) | 0.050 | 0.33 |
| Frontal lobe | 0.33 ( | 0.055 | 0.33 |
| Parietal lobe | 0.18 ( | 0.087 | 0.43 |
| Temporal lobe | 0.19 (0.002, 0.37) | 0.047 | 0.33 |
| Corpus callosum | 0.001 ( | 0.90 | 0.90 |
| Hippocampus | 0.0007 ( | 0.59 | 0.90 |
Note: The associations are expressed as the linear regression coefficients (95% CI, cubic centimeters) per 0.5-point increment in the continuous variable of MIND score using linear regression models. All models were adjusted for intracranial volume, age, race/ethnicity, U.S. regions, education levels, employment, smoking status, alcohol consumption, BMI, physical activity, medical histories of hypertension, diabetes, hypercholesterolemia, and cardiovascular diseases, WHI-HRT treatment assignment, and total energy intake. The -values were adjusted for multiple comparisons with the Benjamini-Hochberg procedure. BMI, body mass index; CI, confidence interval; MIND, Mediterranean–DASH Intervention for Neurodegenerative Delay; MRI, magnetic resonance imaging; WHI-HRT, Women’s Health Initiative Hormone Replacement Therapy trial.
The associations [adjusted ] between exposure before MRI and normal-appearing brain volumes (measured by MRI in 2005–2006) stratified by baseline MIND score ().
| Categories | MIND diet score | MIND diet score | Unadjusted | Benjamini-Hochberg adjusted |
|---|---|---|---|---|
| Total brain | 0.69 | 0.78 | ||
| Normal brain | 1.04 ( | 0.78 | 0.78 | |
| Total white matter | 0.16 ( |
|
| |
| Frontal lobe | 0.70 ( |
| 0.0011 | |
| Parietal lobe | 0.90 ( |
| 0.0021 | |
| Temporal lobe |
| 0.0021 | ||
| Corpus callosum | 0.45 | 0.78 | ||
| Hippocampus | 0.48 | 0.78 |
Note: The associations are expressed as the linear regression coefficients (95% confidence interval, cubic centimeters) per interquartile () increment in the continuous variable of exposure prior to the MRI examination. All models were constructed using linear regression models with the adjustment for intracranial volume, age, race/ethnicity, U.S. regions, education levels, employment, smoking status, alcohol consumption, BMI, physical activity, medical histories of hypertension, diabetes, hypercholesterolemia, and cardiovascular diseases, and WHI-HRT treatment assignment. The multiplicative product of the continuous exposure and the dichotomous variable of MIND score levels was included in the models to test for significant interactions. The -values of the interaction terms were adjusted for multiple comparisons with the Benjamini-Hochberg procedure. BMI, body mass index; CI, confidence interval; MIND, Mediterranean–DASH Intervention for Neurodegenerative Delay; MRI, magnetic resonance imaging; WHI-HRT, Women’s Health Initiative Hormone Replacement Therapy trial.